• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗 p200 天疱疮。

Anti-p200 pemphigoid.

机构信息

Department of Dermatology, University of Luebeck, Luebeck, Germany.

Department of Dermatology, Kurume University School of Medicine, Kurume, Japan.

出版信息

J Am Acad Dermatol. 2014 Jul;71(1):185-91. doi: 10.1016/j.jaad.2014.02.036. Epub 2014 Apr 24.

DOI:10.1016/j.jaad.2014.02.036
PMID:24767733
Abstract

Anti-p200 pemphigoid is a rare subepidermal blistering skin disease. Patients' autoantibodies label the dermal side of 1 mol/L NaCl-split human skin by indirect immunofluorescence microscopy and recognize a 200-kd protein by immunoblotting of human dermal extract. Clinically, anti-p200 pemphigoid is characterized by tense blisters and vesicles, erosions, and urticarial plaques, closely resembling bullous pemphigoid and the inflammatory variant of epidermolysis bullosa acquisita. Recently, 90% of anti-p200 pemphigoid sera were shown to recognize laminin γ1. The C-terminus of laminin γ1 was identified as an immunodominant region and in its recombinant form was used by immunoblotting and enzyme-linked immunosorbent assay for the serologic diagnosis of this disease. Subsequent ex vivo and in vivo studies were, however, unable to show pathogenic activity of antilaminin γ1 antibodies. Both patients' sera and sera depleted from antilaminin γ1 antibodies induced subepidermal splitting in an ex vivo model of autoantibody-mediated leukocyte-dependent neutrophil activation. Antilaminin γ1 antibodies appear to be useful biomarkers that will further facilitate the diagnosis of anti-p200 pemphigoid. The true identity of the pathogenetically relevant autoantigen of this disease, which may either be a yet unknown isoform of laminin γ1 or even another 200-kd protein of the dermoepidermal junction, still needs to be elucidated.

摘要

抗 p200 天疱疮是一种罕见的表皮下水疱性皮肤病。患者的自身抗体通过间接免疫荧光显微镜标记 1mol/L NaCl 分离的人皮肤的真皮侧,并通过免疫印迹分析人真皮提取物识别 200kD 蛋白。临床上,抗 p200 天疱疮的特征是紧张性水疱和大疱、糜烂和荨麻疹样斑块,与大疱性类天疱疮和获得性大疱性表皮松解症的炎症变异型非常相似。最近,90%的抗 p200 天疱疮血清被证明识别层粘连蛋白 γ1。层粘连蛋白 γ1 的 C 末端被确定为免疫优势区,其重组形式用于免疫印迹和酶联免疫吸附试验来诊断这种疾病。然而,随后的体外和体内研究未能显示抗层粘连蛋白 γ1 抗体的致病性活性。在体外抗体介导的白细胞依赖性中性粒细胞激活模型中,患者血清和从抗层粘连蛋白 γ1 抗体中耗尽的血清都能诱导表皮下水疱分离。抗层粘连蛋白 γ1 抗体似乎是有用的生物标志物,将进一步促进抗 p200 天疱疮的诊断。这种疾病的潜在相关自身抗原的真实身份,可能是尚未被发现的层粘连蛋白 γ1 同种型,甚至是真皮表皮连接的另一个 200kD 蛋白,仍需要阐明。

相似文献

1
Anti-p200 pemphigoid.抗 p200 天疱疮。
J Am Acad Dermatol. 2014 Jul;71(1):185-91. doi: 10.1016/j.jaad.2014.02.036. Epub 2014 Apr 24.
2
Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.抗 p200 天疱疮的实验室诊断和临床特征。
JAMA Dermatol. 2016 Aug 1;152(8):897-904. doi: 10.1001/jamadermatol.2016.1099.
3
From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid.从抗 p200 天疱疮到抗层粘连蛋白 γ1 天疱疮。
J Dermatol. 2010 Mar;37(3):231-8. doi: 10.1111/j.1346-8138.2009.00793.x.
4
Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid.抗 p200 型天疱疮自身抗体的简单酶联免疫吸附试验的建立。
Br J Dermatol. 2011 Jan;164(1):76-82. doi: 10.1111/j.1365-2133.2010.10056.x. Epub 2010 Dec 6.
5
Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease.抗p200类天疱疮:一种新型自身免疫性表皮下大疱病。
J Dermatol. 2007 Jan;34(1):1-8. doi: 10.1111/j.1346-8138.2007.00208.x.
6
Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.获得性大疱性表皮松解症和抗p200类天疱疮是主要的表皮下自身免疫性大疱病,通过使用人盐裂皮肤的间接免疫荧光显微镜检查中的基底膜带结合来诊断。
Indian J Dermatol Venereol Leprol. 2017 Sep-Oct;83(5):550-555. doi: 10.4103/ijdvl.IJDVL_678_16.
7
IgA anti-p200 pemphigoid.IgA 型抗p200天疱疮
Arch Dermatol. 2011 Nov;147(11):1306-10. doi: 10.1001/archdermatol.2011.303.
8
Pathogenicity of autoantibodies in anti-p200 pemphigoid.抗 p200 天疱疮中自身抗体的致病性。
PLoS One. 2012;7(7):e41769. doi: 10.1371/journal.pone.0041769. Epub 2012 Jul 24.
9
[Anti-p200 pemphigoid].[抗p200类天疱疮]
Hautarzt. 2019 Apr;70(4):271-276. doi: 10.1007/s00105-019-4376-x.
10
A long-term study of a patient with anti-p200 pemphigoid: correlation of autoantibody levels with disease activity and an example of epitope spreading.抗 p200 天疱疮患者的长期研究:自身抗体水平与疾病活动的相关性和表位扩展的实例。
Br J Dermatol. 2012 Nov;167(5):1179-83. doi: 10.1111/j.1365-2133.2012.11076.x.

引用本文的文献

1
Pemphigoid disease model systems for clinical translation.用于临床转化的类天疱疮疾病模型系统
Front Immunol. 2025 Mar 17;16:1537428. doi: 10.3389/fimmu.2025.1537428. eCollection 2025.
2
An Intriguing Case of Anti-p 200 Pemphigoid Revealing String of Pearl Appearance.一例揭示珍珠串样外观的抗p200类天疱疮的有趣病例。
Indian Dermatol Online J. 2024 Oct 4;16(2):294-295. doi: 10.4103/idoj.idoj_51_24. eCollection 2025 Mar-Apr.
3
Bullous pemphigoid.大疱性类天疱疮
Nat Rev Dis Primers. 2025 Feb 20;11(1):12. doi: 10.1038/s41572-025-00595-5.
4
Anti-p200 Pemphigoid Mimicking Acquired Reactive Perforating Collagenosis.模仿获得性反应性穿通性胶原病的抗p200类天疱疮
Acta Derm Venereol. 2024 Sep 9;104:adv40627. doi: 10.2340/actadv.v104.40627.
5
State-of-the-art diagnosis of autoimmune blistering diseases.自身免疫性水疱病的最新诊断方法。
Front Immunol. 2024 Jun 6;15:1363032. doi: 10.3389/fimmu.2024.1363032. eCollection 2024.
6
[Rare variants of pemphigoid diseases].[类天疱疮疾病的罕见变体]
Dermatologie (Heidelb). 2022 Dec;74(12):937-947. doi: 10.1007/s00105-023-05242-2. Epub 2023 Oct 17.
7
[Pemphigoid diseases in older adults].[老年人的类天疱疮疾病]
Dermatologie (Heidelb). 2023 Sep;74(9):687-695. doi: 10.1007/s00105-023-05209-3. Epub 2023 Aug 18.
8
Epidermolysis Bullosa Acquisita-Current and Emerging Treatments.获得性大疱性表皮松解症——当前及新出现的治疗方法
J Clin Med. 2023 Feb 1;12(3):1139. doi: 10.3390/jcm12031139.
9
Case Report of a Novel Association between Anti-p200 Pemphigoid and Acquired Haemophilia A.抗p200类天疱疮与获得性血友病A新型关联的病例报告
Ann Dermatol. 2023 Feb;35(1):61-65. doi: 10.5021/ad.20.301.
10
Current and Innovated Managements for Autoimmune Bullous Skin Disorders: An Overview.自身免疫性大疱性皮肤病的当前及创新管理:概述
J Clin Med. 2022 Jun 19;11(12):3528. doi: 10.3390/jcm11123528.